Prudential Financial
SNDX icon

Prudential Financial’s Syndax Pharmaceuticals SNDX Stock Holding History

Prudential Financial’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
14,680
+1,270
+9% +$26.4K ﹤0.01% 2081
2026
Q1 		$313K Buy
+13,410
New +$291K ﹤0.01% 2012
2025
Q4 		– Sell
-10,395
Closed -$160K – 2426
2025
Q3 		$160K Buy
10,395
+45
+0.4% +$589 ﹤0.01% 2239
2025
Q2 		$96.9K Buy
+10,350
New +$114K ﹤0.01% 2288
2024
Q4 		– Sell
-38,290
Closed -$737K – 2653
2024
Q3 		$737K Sell
38,290
-96,140
-72% -$1.99M ﹤0.01% 2044
2024
Q2 		$2.76M Buy
134,430
+118,670
+753% +$2.48M ﹤0.01% 1231
2024
Q1 		$375K Buy
+15,760
New +$351K ﹤0.01% 2267
2023
Q4 		– Sell
-134,470
Closed -$2.1M – 2710
2023
Q3 		$2.1M Sell
134,470
-34,300
-20% -$649K ﹤0.01% 1336
2023
Q2 		$3.53M Sell
168,770
-16,935
-9% -$353K 0.01% 1084
2023
Q1 		$3.92M Buy
185,705
+46,030
+33% +$1.15M 0.01% 974
2022
Q4 		$3.55M Buy
139,675
+34,005
+32% +$793K 0.01% 1021
2022
Q3 		$2.54M Buy
+105,670
New +$2.37M ﹤0.01% 1189
2020
Q3 		– Sell
-13,170
Closed -$195K – 2469
2020
Q2 		$195K Sell
13,170
-12,138
-48% -$185K ﹤0.01% 2272
2020
Q1 		$278K Sell
25,308
-2,050
-7% -$19.2K ﹤0.01% 2090
2019
Q4 		$240K Sell
27,358
-200
-0.7% -$1.47K ﹤0.01% 2280
2019
Q3 		$206K Buy
27,558
+6,448
+31% +$58.7K ﹤0.01% 2313
2019
Q2 		$197K Buy
+21,110
New +$154K ﹤0.01% 2346

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Prudential Financial's SNDX Position: Q2 2026 in Review

Prudential Financial increased its Syndax Pharmaceuticals (SNDX) stake by 9.5% in Q2 2026, buying an estimated $26.4K and bringing the position to 14,680 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Prudential Financial first reported a position in SNDX in Q2 2019 and has held it in 17 quarters since. The position peaked at $3.92M in Q1 2023. 243 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • Prudential Financial held 14,680 shares of Syndax Pharmaceuticals worth $321K as of Q2 2026.
  • Prudential Financial bought 1,270 Syndax Pharmaceuticals shares in Q2 2026, an estimated $26.4K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2081 holding.
  • Prudential Financial first reported a position in Syndax Pharmaceuticals in Q2 2019 and has held it in 17 quarters since.
  • Prudential Financial's Syndax Pharmaceuticals position peaked at $3.92M in Q1 2023.
  • 243 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.